# Solving Challenging Diagnoses Through Ultra-long Read Sequencing

> **NCT06775613** · NA · ACTIVE_NOT_RECRUITING · sponsor: **IRCCS Azienda Ospedaliero-Universitaria di Bologna** · enrollment: 15 (actual)

## Conditions studied

- Variant Nucleotide

## Interventions

- **GENETIC:** Long-read sequencing

## Key facts

- **NCT ID:** NCT06775613
- **Lead sponsor:** IRCCS Azienda Ospedaliero-Universitaria di Bologna
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-03-10
- **Primary completion:** 2024-03-20
- **Final completion:** 2025-12-31
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2026-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06775613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06775613, "Solving Challenging Diagnoses Through Ultra-long Read Sequencing". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06775613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*